Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 5/20 | 0.49 |
| ▸ | NTSR1 | P30989 | 3/20 | 0.48 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.48 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.47 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.47 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.45 |
| ▸ | NPY2R | P49146 | 7/20 | 0.45 |
| ▸ | NPY4R | P50391 | 7/20 | 0.45 |
| ▸ | NPY5R | Q15761 | 7/20 | 0.45 |
| ▸ | NPY1R | P25929 | 5/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | RAMP3 | O60896 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31688339 | 0.94 | CAPN1 (0.51) | CALCRNTSR1CAPN1NTSR2NPY2R | |
| SCHEMBL31688350 | 0.94 | CALCR (0.50) | CALCRNTSR1CAPN1CRHR1CRHR2 | |
| SCHEMBL31688307 | 0.92 | CALCR (0.49) | CALCRNTSR1CAPN1CRHR1CRHR2 | |
| SCHEMBL31683366 | 0.88 | CALCR (0.56) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL30478749 | 0.88 | CALCR (0.56) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL29456320 | 0.86 | NTSR1 (0.53) | CALCRNTSR1CRHR1CRHR2NTSR2 | |
| SCHEMBL30277957 | 0.86 | NPY2R (0.58) | CALCRNPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29657237 | 0.86 | CAPN1 (0.46) | CALCRNTSR1CAPN1NTSR2NPY2R | |
| SCHEMBL31000891 | 0.85 | CALCR (0.57) | CALCRCRHR1CRHR2NPY2RNPY4R | |
| SCHEMBL30495714 | 0.85 | CALCR (0.58) | CALCRCRHR1CRHR2NPY2RNPY4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220073636-A1 | ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L | DOMANTIS LIMITED (GB) | 2022-03-10 | — | — | US | disclosed |